Industry Analysis & Industry Trends
In the past five years, the global recession tempered demand for nonessential health products and reduced funding for biotechnology research and development from private investors. Despite these factors, industry firms thrived on the back of technological advances that facilitated new discoveries and stimulated greater demand from firms in the pharmaceuticals and agricultural sectors. Industry growth is forecast to continue skyrocketing in the next five-year period as investment in biotechnology from around the world increases, particularly from emerging economies... read more
The Global Biotechnology industry uses high levels of capital, but also invests significantly into labor due to the knowledge-intensive nature of the industry. For every dollar spent on labor, $0.42 is spent on capital, making the company slightly more capital intensive.
Generally, for companies with fewer than 50 employees, scientists constitute a slightly larger share of the technical workforce. This is consistent with the more research-focused nature of smaller firms. Larger firms tend to have more engineers largely due to their heavier focus on manufacturing and revenue-earning positions, such as sales. General operations, marketing, and financial managers make up almost half of the workforce... read more